RABISIN, ενέσιμο εναιώρημα
RABISIN, ενέσιμο εναιώρημα
Authorised
- Rabies virus, strain G52, Inactivated
Product identification
Medicine name:
RABISIN, ενέσιμο εναιώρημα
Active substance:
- Rabies virus, strain G52, Inactivated
Target species:
-
Horse
-
Cattle
-
Sheep
-
Dog
-
Cat
-
Ferret
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain G52, Inactivated2.09log 10 optical density 501.00dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Horse
-
Not applicableno withdrawal period
-
- Cattle
-
Not applicableno withdrawal period
-
- Sheep
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
- Cat
-
Not applicableno withdrawal period
-
- Ferret
-
Not applicableno withdrawal period
-
-
Subcutaneous use
- Cattle
-
Not applicableno withdrawal period
-
- Sheep
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
- Cat
-
Not applicableno withdrawal period
-
- Ferret
-
Not applicableno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 57429/02-06-2020/K-0013001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: